This grant from NIDA aims to address research gaps in the implementation of Pre-Exposure Prophylaxis (PrEP) among substance users to improve PrEP management and effectiveness. With limited systematic data on PrEP use among substance users, the grant seeks to understand the impact of substance use on PrEP effectiveness, management, adherence, and potential unintended consequences. Research should focus on informing better PrEP implementation strategies for substance users, considering their unique health risk behaviors and challenges. Closing date: Nov 08, 2019.
Opportunity ID: 316018
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-20-013 |
| Funding Opportunity Title: | PrEP for HIV Prevention among Substance Using Populations (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 16, 2019 |
| Last Updated Date: | May 16, 2019 |
| Original Closing Date for Applications: | Nov 08, 2019 |
| Current Closing Date for Applications: | Nov 08, 2019 |
| Archive Date: | Dec 14, 2019 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts County governments Special district governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Small businesses State governments City or township governments Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | NIDA is interested in research that addressing research gaps related to PrEP and its use among substance users, with the goals of improving PrEP management and implementation. Current US Public Health Service PrEP guidelines recommend PrEP for people who inject drugs (PWID) and mention alcohol and illicit drug use as potential concerns for clinical management. Only one clinical trial has evaluated PrEP among PWID and systematic data regarding the broader use of PrEP among substance users are limited. There is a need to better understand the effects of substance use on PrEP effectiveness and better inform PrEP implementation among substance users. More systematic data are needed regarding the impact of substance use on PrEP management and adherence, along with investigating potential unintended consequences of PrEP use that may be unique to substance users such as changes in harm reduction practices, as well as substance use as a contributor to health risk behaviors with consequences such as increased occurrence of STIs. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-013.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | FORMS-E | PKG00251020 | Oct 08, 2019 | Nov 08, 2019 | View |
Package 1
Mandatory forms
316018 RR_SF424_2_0-2.0.pdf
316018 PHS398_CoverPageSupplement_4_0-4.0.pdf
316018 RR_OtherProjectInfo_1_4-1.4.pdf
316018 PerformanceSite_2_0-2.0.pdf
316018 RR_KeyPersonExpanded_2_0-2.0.pdf
316018 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
316018 RR_Budget_1_4-1.4.pdf
316018 RR_SubawardBudget30_1_4-1.4.pdf
316018 PHS398_ModularBudget_1_2-1.2.pdf
316018 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
